A reminder about consent

From May 2016 all patients in the Registry will need to be consented; there are four separate consent questions and our experience so far suggests patients tend to consent to all.

  1. Informed consent for Registry. This allows personal demographic and clinical data to be sent to the IBD Registry. If patients say NO to this then the subsequent questions are not applicable.
  2. Informed consent for linkage. This allows HSCIC to use NHS numbers to extract and link to past Hospital Episode Statistics and then repeat the extraction each year as new HES data is published. It also allows other linkages such as cross-border activity with Wales and Scotland, accessing the mortality register held by Office of National Statistics and potentially other national audits such as bowel cancer.
  3. Informed consent for research. This allows data to be used by researchers who have received Registry approval to access the Registry data.
  4. Informed consent to be contacted for future research studies. This allows data to be matched against criteria for research projects (e.g. a study into side effects from a particular type of treatment). If a patient seems eligible, HSCIC will contact their local clinical team.

There’s more information on consent at https://ibdregistry.org.uk/resources/consent-materials/and https://ibdregistry.org.uk/information-for-patients/

Find out more about…

Latest News

For clinical teams: next submission is 10 July 2020

Important information for Registry-participating clinical teams: with the COVID-19 outbreak, to ease pressure on clinical teams we postponed the last (April) submission deadline.  The next submission deadline is 10 July 2020 for data to the end of June, including all...

read more

Update on the COVID-19 UK IBD Tool for patients

Over 32,000 people in the UK with IBD have self-assessed their risk since launch on the 1 April 2020.  Between them, they have identified the 175 hospitals (Trusts and Health Boards) that provide them with care, and the data has been shared back to their doctors which...

read more

Abbreviated clinician news for IBD Teams – March 2020

Given the special circumstances putting pressure on IBD teams and wider health services, we have created some in-depth articles below in an easy to read format:  Switchers: Changing originator biologic to biosimilar Changing originator biologic to biosimilar With many...

read more

Registry surpasses 60,000 patient records

Huge congratulations to IBD clinical teams across the country - we have surpassed the 60,000 patient record mark. At time of writing we hold 63,181 records. 62 IBD teams submitted for this last quarter, 24% more than the same period last year. Figure: number of...

read more
%d bloggers like this: